4.2 Article

Comparison of three alternatives for the management of moderate asthma in children aged 6-11 years: a cost-utility analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Economics

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

Don Husereau et al.

Summary: The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. The new CHEERS 2022 statement replaces previous guidance and reflects the need for guidance that can be applied to all types of health economic evaluation and includes stakeholder involvement.

VALUE IN HEALTH (2022)

Article Allergy

Are we overcoming our inability to have pediatric patients properly use inhaled corticosteroids by inappropriately escalating their therapy?

Carlos E. Rodriguez-Martinez et al.

Summary: This narrative review provides potential methods and strategies for effectively assessing and managing poor adherence and/or misuse of inhalers in difficult-to-treat pediatric asthmatic patients. Validated self-reported questionnaires, weighing inhaler canisters, and pharmacy records are suggested as suitable methods for assessing adherence. Additionally, a strong physician-parent/patient partnership is highlighted as a crucial factor in improving adherence.

JOURNAL OF ASTHMA (2022)

Article Allergy

Adherence to therapy regimen by children with asthma and their parents

Alina Trojanowska et al.

Summary: The study revealed that compliance with medical recommendations and therapy in children with asthma and their parents was not optimal, mainly depending on the severity of the disease, the child's age, and knowledge about treatment. There is a need for ongoing education of asthmatic children and their parents on recommended therapy.

POSTEPY DERMATOLOGII I ALERGOLOGII (2022)

Article Health Care Sciences & Services

Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia

Oscar Espinosa et al.

Summary: This study examined the healthcare system of the middle-income country Colombia, estimating the cost-effectiveness threshold and exploring the variation of health expenditures and outcomes. The threshold was found to be around one times the GDP per capita, providing valuable insights for decision-making in a managed healthcare system.

HEALTH POLICY AND PLANNING (2022)

Article Health Policy & Services

Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma

Jefferson Antonio Buendia et al.

Summary: This study evaluated the cost-effectiveness of asthma management using fractional exhaled nitric oxide monitoring in patients between 4 and 18 years of age. The results showed that fractional exhaled nitric oxide monitoring was associated with lower total cost and higher QALYs compared to standard therapy, making it a cost-effective option for treating mild to moderate allergic asthma in this age group.

COST EFFECTIVENESS AND RESOURCE ALLOCATION (2021)

Article Respiratory System

Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma

Jefferson Antonio Buendia et al.

Summary: The study found that triple therapy is cost-effective compared to dual therapy for patients with severe asthma, with a potential gain of 1.55 QALYs per patient per year. Sensitivity analysis showed that the base-case results were robust to variations in assumptions and parameters.

BMC PULMONARY MEDICINE (2021)

Article Allergy

Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma

Helen K. Reddel et al.

Summary: This post hoc pooled analysis of SYGMA 1 and 2 showed that as-needed BUD-FORM was superior to maintenance BUD and similar to as-needed terbutaline in reducing severe exacerbations in adolescents with mild asthma. Adherence to maintenance treatment was higher in the BUD-FORM group compared to the BUD maintenance group, and no new safety concerns were identified.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2021)

Letter Allergy

Cost-utility of tiotropium for children with severe asthma in patients aged 1-5 years

Jefferson Antonio Buendia et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2021)

Review Respiratory System

ICS-formoterol reliever versus ICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis

Lee Hatter et al.

Summary: As-needed inhaled corticosteroid (ICS)-formoterol offers a therapeutic alternative to maintenance low-dose ICS plus short-acting beta(2)-agonist (SABA) in asthma, with a prolonged time to first severe exacerbation and reduced daily ICS dose. However, asthma symptom control may be worse in the as-needed group, and there is no significant difference in serious adverse events between the two treatment regimens.

ERJ OPEN RESEARCH (2021)

Article Allergy

Direct medical costs of pediatric asthma exacerbations requiring hospital attendance in a middle-income country

C. E. Rodriguez-Martinez et al.

ALLERGOLOGIA ET IMMUNOPATHOLOGIA (2020)

Review Environmental Sciences

Economic Evaluations Informed Exclusively by Real World Data: A Systematic Review

Elizabeth Parody-Rua et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Article Pediatrics

The cost-utility of intravenous magnesium sulfate for treating asthma exacerbations in children

Jefferson A. Buendia et al.

PEDIATRIC PULMONOLOGY (2020)

Review Allergy

Single inhaler maintenance and reliever therapy in pediatric asthma

Ug Nalin et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Review Pediatrics

Childhood asthma in low and middle-income countries: Where are we now?

Gilberto Bueno Fischer et al.

PAEDIATRIC RESPIRATORY REVIEWS (2019)

Review Pediatrics

The Burden of Pediatric Asthma

Giuliana Ferrante et al.

FRONTIERS IN PEDIATRICS (2018)

Article Respiratory System

The Economic Burden of Asthma in the United States, 2008-2013

Tursynbek Nurmagambetov et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)

Article Allergy

Cost of asthma in children: A nationwide, population-based, cost-of-illness study

Manuel Ferreira de Magalhaes et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2017)

Article Primary Health Care

The frequency of, and adherence to, single maintenance and reliever therapy instructions in asthma: a descriptive analysis

Rachael L. DiSantostefano et al.

NPJ PRIMARY CARE RESPIRATORY MEDICINE (2016)

Article Medicine, General & Internal

Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis

Rik J. B. Loymans et al.

BMJ-BRITISH MEDICAL JOURNAL (2014)

Article Critical Care Medicine

Combination Therapy Salmeterol/Fluticasone Versus Doubling Dose of Fluticasone in Children With Asthma

Anna A. P. H. Vaessen-Verberne et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Article Allergy

Asthma and other allergic conditions in Colombia:: a study in 6 cities

R Dennis et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2004)